Sofosbuvir, Velpatasvir, and Voxilaprevir
1 NDC across 1 manufacturer|0 Generic,1 Brand
▸ More about this market▾ Less
Sofosbuvir, Velpatasvir, and Voxilaprevir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $858.69 to $858.69 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$858.69 – $858.69
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Gilead Sciences, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Hepatitis C Virus NS3/4A Protease Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VOSEVI 400-100-100 MG TABLET | $858.6884 per EA | — |
Frequently Asked Questions
How many Sofosbuvir, Velpatasvir, and Voxilaprevir products are on the market?
The Sofosbuvir, Velpatasvir, and Voxilaprevir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Sofosbuvir, Velpatasvir, and Voxilaprevir?
NADAC reference prices for Sofosbuvir, Velpatasvir, and Voxilaprevir range from $858.6884 to $858.6884 per EA.
Which manufacturers make Sofosbuvir, Velpatasvir, and Voxilaprevir?
1 manufacturer lists Sofosbuvir, Velpatasvir, and Voxilaprevir in NADAC. Ranked by number of NDCs, the largest are Gilead Sciences, Inc. (1).